A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Drug Acquiring Popularity Online
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Professionals Express Worries
However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting products of uncertain source.
Some experts stated the demand for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Content Removal
Based on TikTok, the platform has taken down problematic material and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.
Online Trading Activities
Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and detailed guides for mixing or administering at home.
After moments of entering one community, a vendor shared contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.
Item Information and Pricing
Within these groups, posts show dark colored parcels with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When asked how much time a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for the messaging service said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has previously seen individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to possibly serious medical dangers”.
